Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 3
2019 1
2020 1
2021 3
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
Harrison TW, Chanez P, Menzella F, Canonica GW, Louis R, Cosio BG, Lugogo NL, Mohan A, Burden A, McDermott L, Garcia Gil E, Zangrilli JG; ANDHI study investigators. Harrison TW, et al. Lancet Respir Med. 2021 Mar;9(3):260-274. doi: 10.1016/S2213-2600(20)30414-8. Epub 2020 Dec 22. Lancet Respir Med. 2021. PMID: 33357499 Clinical Trial.
Anxiety, depression and tobacco abstinence.
Almadana Pacheco V, Gómez-Bastero Fernández AP, Valido Morales A, Luque Crespo E, Monserrat S, Montemayor Rubio T. Almadana Pacheco V, et al. Among authors: gomez bastero fernandez ap. Adicciones. 2017 Sep 29;29(4):233-244. doi: 10.20882/adicciones.761. Adicciones. 2017. PMID: 27749973 Free article. English, Spanish.
Effectiveness of Switching to Benralizumab in Severe Refractory Eosinophilic Asthma.
Gómez-Bastero Fernández A, Medina Gallardo JF, Delgado Romero J, Romero Falcón A, Benito Bernáldez C, Gallego Borrego J, Álvarez-Gutiérrez FJ. Gómez-Bastero Fernández A, et al. J Asthma Allergy. 2022 May 25;15:727-735. doi: 10.2147/JAA.S358705. eCollection 2022. J Asthma Allergy. 2022. PMID: 35642210 Free PMC article.
Patient Profile of Drop-Outs From a Pulmonary Rehabilitation Program.
Almadana Pacheco V, Pavón Masa M, Gómez-Bastero Fernández AP, Muñiz Rodríguez AM, Tallón Moreno R, Montemayor Rubio T. Almadana Pacheco V, et al. Among authors: gomez bastero fernandez ap. Arch Bronconeumol. 2017 May;53(5):257-262. doi: 10.1016/j.arbres.2016.06.010. Arch Bronconeumol. 2017. PMID: 27480263 English, Spanish.
Spanish multidisciplinary consensus on the characteristics of severe asthma patients on biologic treatment who are candidates for at-home administration.
Cisneros-Serrano C, Rial MJ, Gómez-Bastero-Fernández A, Igea JM, Martínez-Meca A, Fernández-Lisón LC, López-Carrasco V, Villamañán-Bueno E, Plá-Martí MJ, Chiner E. Cisneros-Serrano C, et al. Among authors: gomez bastero fernandez a. Rev Clin Esp (Barc). 2023 Mar;223(3):154-164. doi: 10.1016/j.rceng.2022.11.001. Epub 2022 Dec 19. Rev Clin Esp (Barc). 2023. PMID: 36549642
Preference for Easyhaler® Over Previous Dry Powder Inhalers in Asthma Patients: Results of the DPI PREFER Observational Study.
Alvarez-Gutiérrez FJ, Gómez-Bastero Fernández A, Medina Gallardo JF, Campo Sien C, Rytilä P, Delgado Romero J. Alvarez-Gutiérrez FJ, et al. Among authors: gomez bastero fernandez a. Patient Prefer Adherence. 2021 Feb 16;15:349-358. doi: 10.2147/PPA.S295710. eCollection 2021. Patient Prefer Adherence. 2021. PMID: 33628015 Free PMC article.
Economic Impact and Clinical Outcomes of Omalizumab Add-On Therapy for Patients with Severe Persistent Asthma: A Real-World Study.
Entrenas Costa LM, Casas-Maldonado F, Soto Campos JG, Padilla-Galo A, Levy A, Álvarez Gutiérrez FJ, Gómez-Bastero Fernández AP, Morales-García C, Gallego Domínguez R, Villegas Sánchez G, Mateos Caballero L, Pereira-Vega A, García Polo C, Pérez Chica G, Martín Villasclaras JJ. Entrenas Costa LM, et al. Among authors: gomez bastero fernandez ap. Pharmacoecon Open. 2019 Sep;3(3):333-342. doi: 10.1007/s41669-019-0117-4. Pharmacoecon Open. 2019. PMID: 30684255 Free PMC article.
Quality Indicators of Asthma Care Derived From the Spanish Guidelines for Asthma Management (GEMA 4.0): A Multidisciplinary Team Report.
Quirce S, Delgado J, Entrenas LM, Grande M, Llorente C, López Viña A, Martínez Moragón E, Mascarós E, Molina J, Olaguibel JM, Pérez de Llano LA, Perpiñá Tordera M, Quintano JA, Rodríguez M, Román-Rodriguez M, Sastre J, Trigueros JA, Valero AL, Zoni AC, Plaza V; ASMAFORUM II Group. Quirce S, et al. J Investig Allergol Clin Immunol. 2017;27(1):69-73. doi: 10.18176/jiaci.0121. J Investig Allergol Clin Immunol. 2017. PMID: 28211351 Free article. No abstract available.